The aim of this study was to determine the impact of surgical interventions on the novel sepsis biomarker soluble urokinase plasminogen activator receptor (suPAR) [4], [6], [8], [9] and to compare with the routinely used laboratory parameters CRP, PCT, and IL-6 in patients with culture-proven bloodstream infection. The gene discussed is CRP; the disease is Sepsis.